Clinical Trial Update: Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glofitamab as a bridge to and/or consolidation after autologous stem cell transplant in patients with relapsed diffuse large B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Glofitamab (Columvi) (glofitamab)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Diffuse Large B Cell Lymphoma Refractory | Phase 2 | Status: NOT_YET_RECRUITING